Data Presented at 10th Society of Vascular and Interventional Annual Meeting
Seems the promise is realised as new clinical data suggests 3D stent technology outperforms straight comparator
High risk CLI patients avoid amputation at 12 months
Unique catheter-based device for the treatment of advanced PAD/Critical Limb Ischemia
Positive two year data reported from Nellix® EVAS FORWARD IDE Trial
First prospective clinical trial to evaluate endovascular aneurysm repair (EVAR) in women
Study paves the way for further sirolimus vs paclitaxel balloon trials below the knee
Results of ASTER study presented at International Stroke Conference
Additional funding from existing investors supports regulatory progress in USA and Japan
GORE® VIABAHN® VBX becomes the only device of its type to gain indication
PulseRider will complement Codman Neuro’s neurovascular portfolio of products for hemorrhagic and ischemic stroke.
“No option” Critical Limb Ischemia Patients may soon have an option as clever, ultrasound-guided revascularisation technology gains EU nod
Past officer at TAVI developer Direct Flow Medical, Daniel Rose will now head up LimFlow with its innovative Critical Limb Ischemia offering
A stent that mimics nature sounds like a good idea and trials are yielding positive outcomes. A new registry should provide real-world data.
Novel balloon catheter with nitinol “scoring” element gains CE mark
U.S company, FlowAid Medical Technologies Corp., has received CE mark approval for its FA100 SCCD Sequential Contraction Compression Device.